0001144204-19-003774.txt : 20190130
0001144204-19-003774.hdr.sgml : 20190130
20190130161832
ACCESSION NUMBER: 0001144204-19-003774
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190128
FILED AS OF DATE: 20190130
DATE AS OF CHANGE: 20190130
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Herskowitz Neil
CENTRAL INDEX KEY: 0001298246
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38114
FILM NUMBER: 19552145
MAIL ADDRESS:
STREET 1: 2109 BROADWAY, SUITE 206
CITY: NEW YORK
STATE: NY
ZIP: 10023
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVENUE THERAPEUTICS, INC.
CENTRAL INDEX KEY: 0001644963
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 474113275
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 GANSEVOORT STREET
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
BUSINESS PHONE: 781-652-4500
MAIL ADDRESS:
STREET 1: 2 GANSEVOORT STREET
STREET 2: 9TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10014
4
1
tv512042_form4.xml
FORM 4
X0306
4
2019-01-28
0
0001644963
AVENUE THERAPEUTICS, INC.
ATXI
0001298246
Herskowitz Neil
C/O AVENUE THERAPEUTICS, INC.
2 GANSEVOORT STREET, 9TH FLOOR
NEW YORK
NY
10014
1
0
0
0
Common Stock
2019-01-28
4
P
0
1447
5.84
A
68610
D
Common Stock
2019-01-29
4
P
0
8553
5.91
A
77163
D
Reflects the weighted average purchase price of multiple same-day open market purchase transactions effected by the Reporting Person on the same day at different prices through a purchase order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one dollar price range. The range of prices for the purchase transactions on January 28, 2019 was $5.82 to $5.89 and the range of prices for the purchase transactions on January 29, 2019 was $5.86 to $5.99. The reporting person hereby undertakes to provide upon request by the Securities Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
Includes 64,663 shares of restricted stock.
/s/ Lucy Lu, M.D., Attorney-in-Fact
2019-01-30